-
公开(公告)号:US20240261446A1
公开(公告)日:2024-08-08
申请号:US18561172
申请日:2021-11-17
Applicant: UNIVERSITÉ DE LIÈGE , CENTRE HOSPITALIER UNIVERSITAIRE DE LIÈGE , VRIJE UNIVERSITEIT BRUSSEL , KTH HOLDING AB
Inventor: Jo Caers , Elodie Duray , Mireille Dumoulin , Matthias D'Huyvetter , Amelie Eriksson Karlström
CPC classification number: A61K51/1096 , A61K51/0491 , A61K51/0495 , A61K51/1027 , A61K51/1069 , A61P35/00 , C07K16/2896 , G01N33/57492 , A61K2039/507 , C07K2317/565 , G01N33/57426 , G01N2333/70596
Abstract: The present invention relates to medical imaging, disease monitoring and theranostic approaches in neoplastic diseases of certain anti-CD38 single-domain antibodies (sdAb).
-
公开(公告)号:US11718578B2
公开(公告)日:2023-08-08
申请号:US17581578
申请日:2022-01-21
Applicant: Université de Liège
Inventor: Thomas Toupy , Romaric Gerardy , Jean-Christophe Monbaliu , Diego Collin , Victor-Emmanuel Kassin
IPC: C07C209/80 , C07C209/86
CPC classification number: C07C209/80 , C07C209/86
Abstract: The invention provides a method for synthesizing a compound of formula
wherein each R independently represents an optionally substituted aryl, heteroaryl, alkyl, perfluoroalkyl, cycloalkyl, alkoxy, aryloxy, acyl, carboxyl, hydroxyl, halogen, amino, nitro, cyano, sulfo or sulfhydryl group, in ortho, meta or para position to the cycloalkylamine moiety; R1 and R2 each independently represents a hydrogen atom, a lower alkyl group or a cycloalkyl group; R3 represents a hydrogen group, substituted aryl, heteroaryl, alkyl, perfluoroalkyl, cycloalkyl, alkoxy, aryloxy group; Y represents an oxygen atom, a sulfur atom, a NH group, a NR4 group or a CH2 group;
R4 represents a hydrogen atom or an alkyl, aryl or a heteroaryl group; and n and m each independently represents an integer from 1 to 5; or a pharmaceutically acceptable salt thereof; or a precursor thereof; wherein the method comprises one or more of the following steps: (a) reacting a compound of formula (II)
wherein R, R3, Y, n and m are as defined above in relation to the compound of formula (I) with an oxygenating agent, a first additive and a second additive in a solvent in a fluidic network or in a batch process under thermal and/or photochemical conditions to form a compound of formula (III):
wherein R, R3, Y, n and m are as defined above in relation to the compound of formula (I), (b) reacting a compound of formula (III) with a nitrogen containing nucleophile in the presence of a third additive and/or a solvent in the fluidic network or in a batch process under thermal conditions to form a compound of formula (IV):
wherein R, R1, R2, R3, Y, n and m are as defined above in relation to the compound of formula (I); and/or
(c) reacting a compound of formula (IV) in a fluidic network or in a batch process, optionally in the presence of a fourth additive, under thermal conditions to form a compound of formula (I); wherein one or more of steps (a), (b) and/or (c) is carried out in a fluidic network that comprises micro- and/or meso-channels having an internal dimension of from 100 μm to 2000 μm.-
公开(公告)号:US11631837B2
公开(公告)日:2023-04-18
申请号:US16482570
申请日:2018-01-29
Applicant: UNIVERSITÉ DE LIÈGE
Inventor: Frédéric Boschini , Caroline Piffet , Rudi Cloots
IPC: H01M4/04 , H01M4/62 , H01M10/052 , H01M8/0223 , H01M10/05 , H01M4/13 , H01M4/02
Abstract: A composition comprises: an at least partially hydrolysed polyvinyl acetate component having an hydrolysation degree of at least 5%; a polyalkylene glycol component having a number average molecular mass Mn lower than 9000 g/mol and consisting of one or more substances selected from the group consisting of polyethylene glycol, polypropylene glycol, copolymers of ethylene glycol and propylene glycol, and their derivatives; a positive or negative electrode active component; and a conductive component; wherein the mass ratio between the at least partially hydrolysed polyvinyl acetate component and the positive or negative electrode active component equals at least 0.12 and at most 0.30, and wherein the mass ratio between the polyalkylene glycol component and the positive or negative electrode active component equals at least 0.012 and at most 0.10.
-
公开(公告)号:US11329279B2
公开(公告)日:2022-05-10
申请号:US16307728
申请日:2017-05-17
Applicant: Université de Liège
Inventor: Alexandre Leonard , Marie-Laure Piedboeuf , Nathalie Job
IPC: H01M4/04 , H01M4/36 , H01M4/1315 , H01M4/133 , H01M4/1391 , H01M4/1393 , H01M4/525 , H01M4/62 , H01M4/66 , H01M4/88 , H01M10/54 , H01M4/58 , H01M4/587 , H01M4/1397 , H01M4/485 , H01M4/136 , H01M4/1395 , H01M4/38 , H01M4/131
Abstract: A process to prepare an electrode for an electrochemical storage device by spraying an aqueous slurry composition comprising water, xanthan gum, a source of conducting carbon particles and an active material on an electrode base. The slurry may be made by first mixing solid xanthan gum with the conducting carbon particles and the active material and secondly adding water to the resulting mixture. Alternatively the slurry is obtained by mixing solid xanthan gum with a carbon-based active material and adding water to the resulting mixture obtained.
-
公开(公告)号:US11255862B2
公开(公告)日:2022-02-22
申请号:US16140851
申请日:2018-09-25
Applicant: Université de Liège
Inventor: Yves Henrotin , Christelle Sanchez , Edwin De Pauw , Gabriel Mazzucchelli
Abstract: The present invention refers to osteomodulin (OMD) protein or fragment of osteomodulin (OMD) protein for use in the prognosis and/or diagnosis of osteoarthritis and/or subchondral bone sclerosis of mammals, preferably human individuals. The present invention further refers to a method for prognosis and/or diagnosis of osteoarthritis and/or subchondral bone sclerosis, comprising the following steps: i) measuring osteomodulin (OMD) protein or a fragment or fragments of osteomodulin (OMD) protein in samples of body fluids of mammalian individuals, preferably human serum samples; ii) judging that decreased levels of osteomodulin (OMD) protein or of said fragment(s) compared to levels in body fluids, preferably serum, of healthy individuals indicate onset of osteoarthritis and/or subchondral bone sclerosis. The present invention also provides an immunological binding partner specifically binding to osteomodulin (OMD) protein or fragment of osteomodulin (OMD) protein for use in the prognosis and/or diagnosis of osteoarthritis and/or subchondral bone sclerosis of mammals, preferably human individuals and a kit comprising said immunological binding partner.
-
6.
公开(公告)号:US20200347121A1
公开(公告)日:2020-11-05
申请号:US16865703
申请日:2020-05-04
Applicant: Université de Liège , Université Paris Descartes , Assistance Publique Hopitaux de Paris , Institut National de la Santé et de la Recherche Médicale
Inventor: Yves HENROTIN , Cécile LAMBERT , Didier BORDERIE , François RANNOU
Abstract: The present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO2 peptide activity for use in the prevention and/or treatment of osteoarthritis. Further, the present invention provides a medicament comprising as active ingredient an inhibitor of Coll2-1 peptide activity and/or an inhibitor of Coll2-1NO2 peptide activity for use in the prevention and/or treatment of rheumatic and musculoskeletal diseases (RMDs).
-
公开(公告)号:US10197610B2
公开(公告)日:2019-02-05
申请号:US14579792
申请日:2014-12-22
Inventor: Jean-Louis Lilien , Huu-Minh Nguyen , Bertrand Godard
Abstract: Method for measuring the power line thermal rating or maximum allowable current rating of an overhead power line with respect to a suspended/anchored cable span (2), comprising at least the following steps of: monitoring a motion of at least one point P of said suspended/anchored cable span (2) over a time interval; monitoring actual line current I, in A, over said time interval; determining an actual sag of said suspended/anchored cable, as a variable of actual line current; measuring or determining the effective wind speed of said suspended/anchored cable span (2) over said time interval; determining a sag reserve DF, in m, for thermal rating, which is the distance between the actual sag and a maximum allowable sag; determining the rate of change, tan(α), in m/A2, of the actual sag versus the square of the line current for the effective wind speed; and determining the power line thermal rating of the overhead power line, or ampacity, linked to a corresponding safety clearance, at measured or determined effective wind speed, by adding the square of actual current I to the ratio of the sag reserve DF by the sag rate of change, tan(α), at the effective wind speed, and taking the square root of that addition, i.e. Ampacity = I 2 + DF tan ( α ) , wherein ampacity is in amperes.
-
公开(公告)号:US20180001290A1
公开(公告)日:2018-01-04
申请号:US15537711
申请日:2015-12-18
Applicant: Prayon , Université De Liège
Inventor: Carlos PAEZ , Dimitri LIQUET , Cédric CALBERG , Benoît HEINRICHS , Christelle ALIÉ
CPC classification number: B01J13/0047 , C23C24/082 , C23C24/085 , H01M4/0452 , H01M4/1391
Abstract: Methods for the deposition of thin films comprising at least preparing a solution containing at least one transition metal oxide powder in a solvent, continuously stirring said solution in order to form a sol, and using said sol in the form of said transition metal oxide film, wherein the powder is subjected to a preliminary preparation step.
-
公开(公告)号:US09689021B2
公开(公告)日:2017-06-27
申请号:US14350646
申请日:2012-10-15
Applicant: UNIVERSITÉ DE LIÈGE , UNIVERSITÉ CATHOLIQUE DE LOUVAIN , UNIVERSITÉ LIBRE DE BRUXELLES , UNIVERSITÉ DE MONS-HAINAUT
Inventor: Alain Brans , Bernard Joris , Michael Delmarcelle , Jacqueline Marchand , Paul Tulkens , Catherine Hammaecher , Erik Goormaghtigh , Joel De Coninck
CPC classification number: C12Q1/34 , C12N9/86 , G01N33/9446 , G01N2333/986
Abstract: The present invention relates to methods for determining the concentration of a free beta-lactam antibiotic in a biological sample. In particular, the present invention relates to methods for measuring a free beta-lactam antibiotic in a biological sample, comprising the steps of: (a) providing at least one class C beta-lactamase, a functional fragment or variant thereof; (b) providing at least one biological sample; (c) contacting said at least one class C beta-lactamase with said at least one biological sample; and (d) determining the concentration of said free beta-lactam antibiotic in said at least one biological sample.
-
公开(公告)号:US20240043647A1
公开(公告)日:2024-02-08
申请号:US18240579
申请日:2023-08-31
Applicant: Université de Liège
Inventor: Christophe DETREMBLEUR , Bruno GRIGNARD , Maxime BOURGUIGNON
CPC classification number: C08J9/02 , C08J9/08 , C08G71/04 , C08G2101/00
Abstract: The present invention relates to a curable isocyanate-free formulation for preparing a polyurethane self-blowing foam comprising at least one multifunctional cyclic carbonate having at least two cyclic carbonate groups at the end of the chain (compound A), at least one multifunctional amine (compound B), water or/and a water source and optionally at least one catalyst (compound D), to a process for preparing said foams and to the thus obtained foams, to a process for recycling the obtained foams and to the thus recycled foams.
-
-
-
-
-
-
-
-
-